ReviewThe American journal of pathology2018

miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ.

Bethany N Hannafon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.